4.5 Article

Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses

Journal

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 88, Issue 11, Pages 4845-4853

Publisher

WILEY
DOI: 10.1111/bcp.15434

Keywords

anaphylaxis; antibiotic reactions; beta-lactams; cystic fibrosis; drug hypersensitivity; piperacillin

Funding

  1. Erica Lederhausen Memorial Foundation, Sweden
  2. Konsul TH C Bergh Foundation, Sweden

Ask authors/readers for more resources

This study investigated the prevalence and clinical features of drug hypersensitivity reactions to antibiotics in cystic fibrosis patients. The results showed that beta-lactams were the most common triggers of reactions, which were mostly mild to moderate and limited to skin, with rare occurrences of severe reactions like anaphylaxis. Patients with hypersensitivity reactions were exposed to significantly more antibiotic courses compared to those without reactions.
Aims Drug hypersensitivity reactions (DHR) to antibiotics are common and a substantial issue in managing patients with cystic fibrosis (CF). This study aimed to assess the prevalence and clinical features as well as risk factors of DHR to antibiotics in CF. Method A 20-year retrospective study was conducted among 226 CF patients (100 children and 126 adults) attending our centre. The Swedish Registry for Cystic Fibrosis and electronic medical records enabled us to ascertain the number and routes of antibiotic courses. All suspected DHR were evaluated. Results The patients had a total of 16 910 antibiotic courses, of which 6832 (40%) were intravenously administered. Of 226 enrolled CF patients, 70 (31%) developed overall 131 DHR to antibiotics. The prevalence of DHR increased with advancing age (P < .001). Beta-lactams elicited 71% of all DHR and piperacillin was the most common single culprit (30% of intravenous and 24% of all DHR). Reactions were mild to moderate and mostly limited to skin; no severe cutaneous adverse reactions were observed. Additionally, anaphylaxis was rare, constituting 2.3% (3/131) of all DHR. Patients with DHR were exposed to significantly more courses of antibiotics than those without DHR (median 124 vs. 46, retrospectively, P < .001). Conclusions DHR to antibiotics, particularly to beta-lactams, are increased in CF patients, and associated with a higher number of cumulative exposures because of recurrent infections. However, severe cutaneous or systemic DHR, such as anaphylaxis, appear to be rare.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available